Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective
about
Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.Hypogammaglobulinemia after cardiopulmonary bypass in infants.Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and PathogensHuman scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.Metabolic and toxicological considerations for sepsis drug treatments.Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.The original sins of clinical trials with intravenous immunoglobulins in sepsis.Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure.IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling (Review).Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureRefractory septic shock: our pragmatic approach
P2860
Q30313854-8BFEC59D-95F0-4222-A3D6-CD28AA230964Q33813616-22C11E27-1D8E-4DAD-B685-6C8A1C74284BQ34661621-94F905D3-A566-4662-80D6-A30A351D2EC9Q35752782-167D0E3B-E5C6-489D-A14F-82A96C2F15D2Q35946361-BE91985D-2C27-40E9-9865-8A33876948F0Q36285360-E8992182-A282-4519-83E0-DE4B0306F4EEQ38045406-CE3F9344-6343-4F5B-9B38-CF2D43377BCBQ38682155-6B6B6588-96FF-4B68-90C1-A5453AEDE115Q41325253-998F11DE-1384-411A-8EF5-41DA5BD8DEBFQ41326071-1A6ED72B-2803-444F-B36B-0DFAFAF82F3AQ41741003-39ADEC7D-61A8-4B9F-B062-3D38F180E49DQ42290901-C1B80E20-2AEE-4F49-8A6B-2CC1A5800ED6Q42364236-1A7225EB-7D5A-4E91-9EA2-14BB29DEE9C2Q47749841-23B17490-5D11-427D-A846-3EE31FE81032Q57175340-C8B2D67D-03AC-4FDF-B454-3E5675626294Q58720877-15E27170-F0CA-4A1E-92C9-9B65305CD3A7
P2860
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bench-to-bedside review: Immun ...... om a critical care perspective
@ast
Bench-to-bedside review: Immun ...... om a critical care perspective
@en
type
label
Bench-to-bedside review: Immun ...... om a critical care perspective
@ast
Bench-to-bedside review: Immun ...... om a critical care perspective
@en
prefLabel
Bench-to-bedside review: Immun ...... om a critical care perspective
@ast
Bench-to-bedside review: Immun ...... om a critical care perspective
@en
P2093
P2860
P921
P356
P1433
P1476
Bench-to-bedside review: Immun ...... om a critical care perspective
@en
P2093
Jo Spencer
Kathryn M Rowan
William A Sewell
P2860
P2888
P356
10.1186/CC10597
P577
2012-12-12T00:00:00Z
P5875
P6179
1050092298